TissueGene Inc - Company Review
TissueGene Inc - Company ReviewSummary
TissueGene Inc (TissueGene) is a clinical-stage bio-pharmaceutical company that focuses on the development of novel regenerative therapies for the treatment of orthopedic disorders. The company’s lead product, Invossa, an allogeneic cell mediated gene therapy used for the treatment of osteoarthritis of knee which is in Phase II trials in the US. Its pipeline products are used for the regeneration of cartilage, disc, bone and nerve, respectively. The company has partnership with Kolon Life Science, to enhance the commercialization of its products by conducting clinical trials actoss the US and Korea. TissueGene is headquartered in Rockville, Maryland, the US
This comprehensive company report of TissueGene Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.